Skip to main content
NCBI home page
Genitourinary Medicine logoLink to Genitourinary Medicine
. 1995 Apr;71(2):120–122. doi: 10.1136/sti.71.2.120

Incidence of symptomatic urinary tract infections in HIV seropositive patients and the use of cotrimoxazole as prophylaxis against Pneumocystis carinii pneumonia.

J K Evans 1, A McOwan 1, R J Hillman 1, G E Forster 1
PMCID: PMC1195467  PMID: 7744401

Abstract

OBJECTIVES--To determine the incidence of symptomatic urinary tract infections in HIV seropositive patients and to assess whether this varies with stage of disease, risk group or the use of co-trimoxazole as prophylaxis against Pneumocystis carinii pneumonia. METHODS--A retrospective case note review of 175 HIV-infected patients attending The Royal London Hospital between July 1988 and December 1992 was performed. A urinary tract infection was defined as a pure culture of > or = 10(5) colony forming units in a mid-stream specimen of urine from a patient with symptoms consistent with a urinary tract infection. RESULTS--Urinary tract infections occurred in 10 (5.7%) of 175 patients, with an incidence of 1.49 per hundred patient years. Urinary tract infections were significantly more common in patients with AIDS or a CD4 lymphocyte count below 0.2 x 10(9)/l (or both) when compared to those without AIDS and a CD4 lymphocyte count above 0.2 x 10(9)/l (5.4 vs. 0.5 urinary tract infections per hundred patient years, p = 0.00005). Women with AIDS or a CD4 count below 0.2 x 10(9)/l (or both) had an incidence of urinary tract infection of 18.5 per hundred patient years. No significant difference was found between the incidence of urinary tract infections in those taking co-trimoxazole as Pneumocystis carinii pneumonia prophylaxis and those taking alternative or no prophylaxis (2.6 vs 6.4 per hundred patient years, p = 0.39). CONCLUSIONS--Urinary tract infection represents a considerable health problem amongst HIV infected patients. Our data show that urinary tract infections are more common in patients with advanced compared with early HIV infection. Cotrimoxazole, when taken by patients as prophylaxis against Pneumocystis carinii pneumonia did not appear to reduce the incidence of urinary tract infection.

Full text

PDF
120

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  1. Bain M., Emmanuel F. X., Willocks L., Cowan F., Brettle R. P. Value of bacteriological screening of urine samples from HIV infected patients. Int J STD AIDS. 1992 Sep-Oct;3(5):360–361. doi: 10.1177/095646249200300511. [DOI] [PubMed] [Google Scholar]
  2. Barnes R. C., Daifuku R., Roddy R. E., Stamm W. E. Urinary-tract infection in sexually active homosexual men. Lancet. 1986 Jan 25;1(8474):171–173. doi: 10.1016/s0140-6736(86)90650-1. [DOI] [PubMed] [Google Scholar]
  3. Carr A., Tindall B., Brew B. J., Marriott D. J., Harkness J. L., Penny R., Cooper D. A. Low-dose trimethoprim-sulfamethoxazole prophylaxis for toxoplasmic encephalitis in patients with AIDS. Ann Intern Med. 1992 Jul 15;117(2):106–111. doi: 10.7326/0003-4819-117-2-106. [DOI] [PubMed] [Google Scholar]
  4. Fauci A. S. The human immunodeficiency virus: infectivity and mechanisms of pathogenesis. Science. 1988 Feb 5;239(4840):617–622. doi: 10.1126/science.3277274. [DOI] [PubMed] [Google Scholar]
  5. Hardy W. D., Feinberg J., Finkelstein D. M., Power M. E., He W., Kaczka C., Frame P. T., Holmes M., Waskin H., Fass R. J. A controlled trial of trimethoprim-sulfamethoxazole or aerosolized pentamidine for secondary prophylaxis of Pneumocystis carinii pneumonia in patients with the acquired immunodeficiency syndrome. AIDS Clinical Trials Group Protocol 021. N Engl J Med. 1992 Dec 24;327(26):1842–1848. doi: 10.1056/NEJM199212243272604. [DOI] [PubMed] [Google Scholar]
  6. Hoepelman A. I., van Buren M., van den Broek J., Borleffs J. C. Bacteriuria in men infected with HIV-1 is related to their immune status (CD4+ cell count). AIDS. 1992 Feb;6(2):179–184. doi: 10.1097/00002030-199202000-00006. [DOI] [PubMed] [Google Scholar]
  7. Lipsky B. A. Urinary tract infections in men. Epidemiology, pathophysiology, diagnosis, and treatment. Ann Intern Med. 1989 Jan 15;110(2):138–150. doi: 10.7326/0003-4819-110-2-138. [DOI] [PubMed] [Google Scholar]
  8. Pinho A. M., Maranconi D. V., Moreira B. M., Rodrigues K. M., Paz N. A., Ramos-Filho C. F., Schechter M. Bacteriuria in patients with CDC group IV manifestations: a prospective study. AIDS. 1991 Mar;5(3):342–342. [PubMed] [Google Scholar]
  9. Wilkie M. E., Almond M. K., Marsh F. P. Diagnosis and management of urinary tract infection in adults. BMJ. 1992 Nov 7;305(6862):1137–1141. doi: 10.1136/bmj.305.6862.1137. [DOI] [PMC free article] [PubMed] [Google Scholar]
  10. Wilson A. P., Tovey S. J., Adler M. W., Grüneberg R. N. Prevalence of urinary tract infection in homosexual and heterosexual men. Genitourin Med. 1986 Jun;62(3):189–190. doi: 10.1136/sti.62.3.189. [DOI] [PMC free article] [PubMed] [Google Scholar]

Articles from Genitourinary Medicine are provided here courtesy of BMJ Publishing Group

RESOURCES